Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Biofrontera (BFRIW) over the last 4 years, with Q3 2025 value amounting to $10000.0.

  • Biofrontera's Short-term Investments rose 2500.0% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10000.0, marking a year-over-year increase of 2500.0%. This contributed to the annual value of $7000.0 for FY2024, which is 9102.56% down from last year.
  • Biofrontera's Short-term Investments amounted to $10000.0 in Q3 2025, which was up 2500.0% from $9000.0 recorded in Q2 2025.
  • Biofrontera's Short-term Investments' 5-year high stood at $10.5 million during Q4 2022, with a 5-year trough of $7000.0 in Q4 2024.
  • Over the past 4 years, Biofrontera's median Short-term Investments value was $10000.0 (recorded in 2024), while the average stood at $2.0 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 9976.06% in 2024, then skyrocketed by 2500.0% in 2025.
  • Biofrontera's Short-term Investments (Quarter) stood at $10.5 million in 2022, then tumbled by 99.26% to $78000.0 in 2023, then tumbled by 91.03% to $7000.0 in 2024, then soared by 42.86% to $10000.0 in 2025.
  • Its Short-term Investments stands at $10000.0 for Q3 2025, versus $9000.0 for Q2 2025 and $7000.0 for Q1 2025.